Deadline for Implementation of USP 800

USP has established a deadline for implementation of USP 800. Here is the information from USP:

“General Chapter <800> was published on February 1, 2016 in the First Supplement to USP 39–NF 34.The Expert Committee approved a delayed
official implementation date of July 1, 2018 to allow entities additional time to implement the standard. With the delayed official date, entities have more than two years to implement this new standard.”

Following is some additional key information about the USP 800 guidelines from USP: (http://www.usp.org/frequently-asked-questions/hazardous-drugs-handling-healthcare-settings):

What is the purpose of General Chapter <800>?
The purpose of the chapter is to describe practice and quality standards for handling hazardous drugs in healthcare settings and help promote patient safety, worker safety, and environmental protection. The new general chapter defines processes intended to minimize the exposure to hazardous drugs in healthcare settings.

Does General Chapter <800> apply to me?
The chapter applies to all healthcare personnel who handle hazardous drug preparations (e.g. pharmacists, pharmacy technicians, nurses, physicians, physician assistants, home healthcare workers, veterinarians, and veterinary technicians). The chapter also covers all healthcare entities that store, prepare, transport, or administer hazardous drugs (e.g., pharmacies, hospitals, other healthcare institutions, patient treatment clinics, physicians’ practice facilities, and veterinarian offices).

What is a hazardous drug?
A hazardous drug is any drug identified as hazardous or potentially hazardous by the National Institute for Occupational Safety and Health (NIOSH) on the basis of at least one of the following six criteria: carcinogenicity, teratogenicity or developmental toxicity, reproductive toxicity in humans, organ toxicity at low doses in humans or animals, genotoxicity, and new drugs that mimic existing hazardous drugs in structure or toxicity. NIOSH maintains a list of antineoplastic and other hazardous drugs used in healthcare settings.

What is the status of the General Chapter <800> and when will General Chapter <800> become official?
General Chapter <800> was published on February 1, 2016 in the First Supplement to USP 39–NF 34.The Expert Committee approved a delayed official implementation date of July 1, 2018 to allow entities additional time to implement the standard. With the delayed official date, entities have more than two years to implement this new standard.

How can I obtain a copy of General Chapter <800>?
General Chapter <800> was published on February 1, 2016 in the First Supplement to USP 39–NF 34. You may purchase the chapter through a subscription to the USP Compounding Compendium or USP-NF.

Ways to Follow USP 800.guru:

USP800.org on Twitter : www.twitter.com/usp800
USP800.org on Blogger : http://usp800.blogspot.com/
USP800.org on LinkedIn : https://www.linkedin.com/company/usp800-guru
USP800.org on Facebook : https://www.facebook.com/USP800

Ways to Follow USP 797.org:

USP797.org on Twitter : www.twitter.com/usp797
USP797.org on Blogger : http://usp797org.blogspot.com/
USP797.org on LinkedIn : https://www.linkedin.com/company/usp797-org-inc-
USP797.org on Facebook: : http://www.facebook.com/usp797org/

To reach USP800.guru:

USP800.guru
1483 York Avenue – #20602
New York, NY 10021
T: 800-974-3109
E: info@usp800.guru
W: www.usp800.guru